ZA201006843B - Novel n-and c-terminal substituted-antagonistic analogs of human gh-rh - Google Patents

Novel n-and c-terminal substituted-antagonistic analogs of human gh-rh

Info

Publication number
ZA201006843B
ZA201006843B ZA2010/06843A ZA201006843A ZA201006843B ZA 201006843 B ZA201006843 B ZA 201006843B ZA 2010/06843 A ZA2010/06843 A ZA 2010/06843A ZA 201006843 A ZA201006843 A ZA 201006843A ZA 201006843 B ZA201006843 B ZA 201006843B
Authority
ZA
South Africa
Prior art keywords
novel
human
terminal substituted
antagonistic analogs
antagonistic
Prior art date
Application number
ZA2010/06843A
Other languages
English (en)
Inventor
Andrew V Schally
Jozsef L Varga
Marta Zarandi
Ren Zhi Cai
Original Assignee
The Univ Of Miami
The United States Of America Represented By The United States Deoartment Of Veteran's Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Univ Of Miami, The United States Of America Represented By The United States Deoartment Of Veteran's Affairs filed Critical The Univ Of Miami
Publication of ZA201006843B publication Critical patent/ZA201006843B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA2010/06843A 2008-03-28 2010-09-27 Novel n-and c-terminal substituted-antagonistic analogs of human gh-rh ZA201006843B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4041808P 2008-03-28 2008-03-28
PCT/US2009/038351 WO2009120831A2 (en) 2008-03-28 2009-03-26 Novel n-and c-terminal substituted antagonistic analogs of gh-rh

Publications (1)

Publication Number Publication Date
ZA201006843B true ZA201006843B (en) 2012-03-28

Family

ID=40886425

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/06843A ZA201006843B (en) 2008-03-28 2010-09-27 Novel n-and c-terminal substituted-antagonistic analogs of human gh-rh

Country Status (11)

Country Link
US (1) US8227405B2 (enExample)
EP (1) EP2288374B1 (enExample)
JP (1) JP5588963B2 (enExample)
CN (1) CN101983068B (enExample)
AU (1) AU2009228244A1 (enExample)
BR (1) BRPI0910873A2 (enExample)
CA (1) CA2718146C (enExample)
IL (1) IL208099A0 (enExample)
MX (1) MX2010010642A (enExample)
WO (1) WO2009120831A2 (enExample)
ZA (1) ZA201006843B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691942B2 (en) * 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
WO2011153491A2 (en) 2010-06-03 2011-12-08 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
CN104582796A (zh) * 2012-06-27 2015-04-29 迈阿密大学 治疗阿尔茨海默病的组合物和方法
EP2934565B1 (en) 2012-12-21 2019-03-13 University of Miami Ghrh agonists for the treatment of ischemic disorders
EP2935317B1 (en) 2012-12-21 2019-03-27 University of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
CA3129405A1 (en) * 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
WO2021011874A1 (en) 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016923A1 (en) * 1990-05-04 1991-11-14 The Administrators Of The Tulane University Educational Fund Novel synthetic grf analogs
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
US6057422A (en) * 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists

Also Published As

Publication number Publication date
WO2009120831A2 (en) 2009-10-01
WO2009120831A8 (en) 2010-09-30
US8227405B2 (en) 2012-07-24
CN101983068B (zh) 2014-12-24
JP2011517675A (ja) 2011-06-16
WO2009120831A3 (en) 2009-12-23
CA2718146A1 (en) 2009-10-01
US20100092539A1 (en) 2010-04-15
CN101983068A (zh) 2011-03-02
IL208099A0 (en) 2010-12-30
MX2010010642A (es) 2011-03-29
CA2718146C (en) 2016-09-20
EP2288374A2 (en) 2011-03-02
JP5588963B2 (ja) 2014-09-10
BRPI0910873A2 (pt) 2015-10-06
AU2009228244A1 (en) 2009-10-01
EP2288374B1 (en) 2017-02-01

Similar Documents

Publication Publication Date Title
IL208099A0 (en) Novel n-and c - terminal substituted - antagonistic analogs of human gh - rh
EP2435390A4 (en) TRANSALCYLATION OF POLYCYCLOHEXYLBENZENES
PL2590521T3 (pl) Kompozycja odżywcza do stymulacji syntezy białek mięśniowych
IL218116A (en) Different peptides that have active and isotope from the gut containing elastin-like peptides
EP2467039A4 (en) WALKING STICK
IL206158A0 (en) Purification of not-glycosylated polypeptides
EP2459206A4 (en) METHODS OF TREATMENT USING THYMUS-BASED COMPOSITIONS
SI2302132T1 (sl) Fluorescentna belilna sredstva disulfo-tipa
TWM370186U (en) Structure improvement of thermoelectric cogeneration
IL211052A0 (en) Synthesis of glatiramer acetate
EP2365821A4 (en) CRYSTALLINE FORM OF LINACLOTIDE
EP2519537A4 (en) CLEANING PROTEINS
EP2435468A4 (en) FIBROMODULINPEPTID
IL216199A (en) A peptide containing the sequence ednimvtfrnqasr
IL212078A0 (en) Antibodies to modified human igf-1/e peptides
EP2478010A4 (en) PART PEPTIDE OF LACRITINE
EP2478001A4 (en) BENEFICIAL PEPTIDE COMPOUNDS OF MU OPIACEOUS RECEPTOR
EP2448958A4 (en) HUMAN MILK PEPTIDES
EP2252306A4 (en) NEW USE OF PROBIOTICS
TWI367205B (en) Preparation of paricalcitol
ZA201203722B (en) Peptide
GB0918321D0 (en) Cyclic peptide synthesis
GB0908711D0 (en) Preparation of labelled compounds
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE